- Home
- BIOA vs DMO Comparison
BIOA vs DMO Comparison
Compare BIOA & DMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOA
- DMO
- Stock Information
- Founded
- BIOA 2015
- DMO 2009
- Country
- BIOA United States
- DMO United States
- Employees
- BIOA N/A
- DMO N/A
- Industry
- BIOA Biotechnology: Pharmaceutical Preparations
- DMO Trusts Except Educational Religious and Charitable
- Sector
- BIOA Health Care
- DMO Finance
- Exchange
- BIOA Nasdaq
- DMO Nasdaq
- Market Cap
- BIOA 153.4M
- DMO N/A
- IPO Year
- BIOA 2024
- DMO N/A
- Fundamental
- Price
- BIOA $4.65
- DMO $11.89
- Analyst Decision
- BIOA Hold
- DMO
- Analyst Count
- BIOA 4
- DMO 0
- Target Price
- BIOA $5.67
- DMO N/A
- AVG Volume (30 Days)
- BIOA 303.9K
- DMO 49.6K
- Earning Date
- BIOA 08-15-2025
- DMO 01-01-0001
- Dividend Yield
- BIOA N/A
- DMO 12.06%
- EPS Growth
- BIOA N/A
- DMO N/A
- EPS
- BIOA N/A
- DMO N/A
- Revenue
- BIOA $1,451,000.00
- DMO N/A
- Revenue This Year
- BIOA N/A
- DMO N/A
- Revenue Next Year
- BIOA N/A
- DMO N/A
- P/E Ratio
- BIOA N/A
- DMO N/A
- Revenue Growth
- BIOA N/A
- DMO N/A
- 52 Week Low
- BIOA $2.88
- DMO $10.00
- 52 Week High
- BIOA $26.62
- DMO $11.80
- Technical
- Relative Strength Index (RSI)
- BIOA N/A
- DMO 52.29
- Support Level
- BIOA N/A
- DMO $11.89
- Resistance Level
- BIOA N/A
- DMO $12.00
- Average True Range (ATR)
- BIOA 0.00
- DMO 0.09
- MACD
- BIOA 0.00
- DMO -0.01
- Stochastic Oscillator
- BIOA 0.00
- DMO 56.00
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.